Contrast enhanced ultrasound should be the initial radiological investigation to characterise focal liver lesions

European Journal of Surgical Oncology

Volumn 36, Issue 1, 2010, Pages 43-46

  Beaton, C ^a   Cochlin, D ^a   Kumar, N ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Contrast ultrasound; Focal liver lesions; Specificity

Indexed keywords

SONOVUE;

ANGIOMYOLIPOMA; ARTICLE; BILE DUCT CARCINOMA; CANCER PATIENT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FATTY LIVER; FEMALE; HEPATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER ABSCESS; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CYST; LIVER HEMANGIOMA; LIVER HYDATID CYST; LIVER INJURY; LIVER METASTASIS; LIVER NODULE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT IDENTIFICATION; PATIENT SAFETY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

CONTRAST MEDIA; FEMALE; HUMANS; LIVER; LIVER DISEASES; LIVER NEOPLASMS; MALE; MICROBUBBLES; PHOSPHOLIPIDS; SENSITIVITY AND SPECIFICITY; SULFUR HEXAFLUORIDE;

EID: 73249116374     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2009.07.187     Document Type: Article

References (13)

1. Lencioni R., Della Pina C., Crocetti L., Bozzi E., and Cioni D. Clinical management of focal liver lesions: the key role of real-time contrast-enhance US. Eur Radiol 17 Suppl. 6 (2007) F73-F79
2. Quaia E., Calliada F., Bertolotto M., et al. Characterisation of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 232 (2004) 420-430
3. Esteban J.M., Mollá M.A., Tomás C., and Maldonado L. Improved detection of liver metastases with contrast-enhanced wideband harmonic imaging: comparison with CT findings. Eur J Ultrasound 15 (2002) 119-126
4. Claudon M., Cosgrove D., Albrecht T., et al., EFSUMB Study Group. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) - update 2008. Ultraschall Med 29 (2008) 28-44
5. Correas J.M., Bridal L., Lesavre A., et al. Ultrasound contrast agents: properties, principles of action, tolerance and artefacts. Eur Radiol 11 (2001) 1316-1328
6. Rettenbacher T. Focal liver lesions: role of contrast-enhanced ultrasound. Eur Radiol 64 (2007) 173-182
7. Bleuzen A., and Tranquart F. Incidental liver lesions: diagnostic value of cadence contrast pulse sequencing (CPS) and SonoVue. Eur Radiol 14 Suppl. 8 (2004) 53-62
8. Dietrich C.A. Characterisation of focal liver lesions with contrast enhanced ultrasonography. Eur J Radiol 51 Suppl. 1 (2004) S9-17
9. Bartolozzi C., and Lencioni R. Contrast-specific ultrasound imaging of focal liver lesions. Eur Radiol 11 Suppl. 11 (2001) E13-E14
10. Leen E., Ceccotti P., Kalogeropoulou C., Angerson W.J., Moug S.J., and Horgan P.G. Prospective multicentre trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography. Am J Radiol 186 (2006) 1551-1559
11. Von Herbay A., Vogt C., Willers R., and Haussinger D. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions. J Ultrasound Med 23 (2004) 1557-1568
12. Soye J.A., Mullan C.P., Porter S., Beattie H., Barltrop A.H., and Nelson W.M. The use of contrast-enhanced ultrasound in the characterisation of focal liver lesions. Ulster Med J 76 1 (2007) 22-25
13. Ohlsson B., Nilsson J., Strenram U., Akerman M., and Tranberg K.G. Percutaneous fine-needle aspiration cytology in the diagnosis and management of liver tumours. Br J Surg 89 (2002) 757-762